Paola Cavalla Selected Research

Paola Cavalla Research Topics

Disease

31	Multiple Sclerosis 11/2022 - 08/2008
6	Relapsing-Remitting Multiple Sclerosis 04/2022 - 08/2014
5	Infections 11/2022 - 01/2015
5	COVID-19 11/2022 - 01/2021
4	Progressive Multifocal Leukoencephalopathy 02/2022 - 08/2014
3	Inflammation (Inflammations) 01/2016 - 08/2007
2	Fatigue 05/2022 - 07/2013
2	Sudden Infant Death (SID) 05/2021 - 01/2020
2	Gliosis 01/2018 - 08/2007
2	Demyelinating Diseases (Demyelinating Disease) 08/2007 - 12/2005
2	Neoplasms (Cancer) 01/2003 - 08/2002
1	Breakthrough Infections 11/2022
1	Lymphopenia (Lymphocytopenia) 04/2022
1	Disease Progression 01/2022
1	Neuromyelitis Optica (Devic's Disease) 11/2019
1	Spontaneous Abortion (Miscarriage) 01/2018
1	Pneumonia (Pneumonitis) 01/2015
1	Rickets (Rachitis) 03/2013
1	Wounds and Injuries (Trauma) 10/2011
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2008
1	Chronic Progressive Multiple Sclerosis 08/2007
1	Glioblastoma (Glioblastoma Multiforme) 01/2003
1	Astrocytoma (Pilocytic Astrocytoma) 08/2002

Drug/Important Bio-Agent (IBA)

9	Natalizumab (Tysabri)FDA Link 11/2022 - 08/2014
4	ocrelizumabIBA 11/2022 - 01/2021
3	Fingolimod Hydrochloride (FTY720)FDA Link 11/2022 - 11/2015
2	COVID-19 VaccinesIBA 11/2022 - 01/2022
2	Interferon-betaIBA 01/2022 - 11/2015
2	Dronabinol (THC)FDA LinkGeneric 10/2020 - 01/2020
2	Rituximab (Mabthera)FDA Link 10/2020 - 11/2019
2	CannabidiolIBA 10/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 10/2020 - 08/2014
2	nabiximols (Sativex)IBA 01/2020 - 01/2017
2	SuspensionsIBA 01/2018 - 11/2015
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2016 - 01/2015
2	ProgranulinsIBA 01/2016 - 10/2011
2	Nerve Growth Factors (Neurotrophins)IBA 01/2016 - 10/2011
1	Methylprednisolone FDA LinkGeneric 07/2022
1	nitazoxanide (NTZ)FDA Link 02/2022
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	Alemtuzumab (Campath)FDA Link 01/2022
1	Particulate MatterIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	teriflunomideIBA 08/2021
1	Monoclonal AntibodiesIBA 10/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Glatiramer Acetate (Copaxone)FDA Link 11/2015
1	Immunomodulating AgentsIBA 01/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2013
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 07/2013
1	Serotonin (5 Hydroxytryptamine)IBA 07/2013
1	Vitamin D FDA LinkGeneric 03/2013
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 03/2013
1	MicroRNAs (MicroRNA)IBA 02/2013
1	HLA-A Antigens (HLA-A)IBA 07/2011
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2008
1	HLA-DR Antigens (HLA-DR)IBA 08/2008
1	Hypnotics and Sedatives (Sedatives)IBA 07/2008
1	Excitatory Amino AcidsIBA 08/2007
1	Glutamic Acid (Glutamate)FDA Link 08/2007
1	Caspase 3 (Caspase-3)IBA 12/2005
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2003
1	F-Box ProteinsIBA 08/2002

Therapy/Procedure

10	Therapeutics 11/2022 - 07/2013
1	Physical Therapy Modalities (Physical Therapy Technique) 05/2022
1	Injections 05/2018
1	Immunotherapy 01/2015
1	Antibiotic Prophylaxis 01/2015